Vasopressin for hemodynamic rescue in catecholamine-resistant vasoplegic shock after resection of massive pheochromocytoma

Anesthesiology

Volumn 101, Issue 4, 2004, Pages 1022-1024

  Augoustides, John G ^a,b   Abrams, Marc ^a   Berkowitz, Darryl ^a   Fraker, Douglas ^a  

^a Department of Anesthesia ^*

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; LABETALOL; NIFEDIPINE; PHENOXYBENZAMINE; VASOPRESSIN;

ADULT; ARTICLE; CANCER SURGERY; CASE REPORT; CATECHOLAMINE RELEASE; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; INTENSIVE CARE; MALE; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RESUSCITATION; SHOCK; TUMOR VOLUME; VASOPLEGIC SHOCK;

ADRENAL GLAND NEOPLASMS; CATECHOLAMINES; HUMANS; MALE; MIDDLE AGED; PHEOCHROMOCYTOMA; SHOCK; VASCULAR DISEASES; VASCULAR RESISTANCE; VASOPRESSINS;

EID: 4644316384     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200410000-00031     Document Type: Article

References (15)

1. Kinney MAO, Narr BJ, Warner MA: Perioperative management of pheochromocytoma. J Cardiothor Vasc Anesth 2002; 16:359-69
2. Bogdonoff DL: Pheochromocytoma: Specialist cases that all must be prepared to treat. J Cardiothor Vasc Anesth 2002; 16:267-9
3. Tan SG, Koay CK, Chan ST: The use of vasopressin to treat catecholamine-resistant hypotension after phaeochromocytoma removal. Anaesth Intensive Care 2002; 30:477-80
4. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, Oz MC, Oliver JA: Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997; 95:1122-5
5. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, Oz MC, Oliver JA: Vasopressin pressor hypersensitivity in vasodilatory septic shock. Crit Care Med 1997; 25:1279-82
6. Argenziano M, Choudri AF, Oz MC, Rose EA, Smith CR, Landry DW: Prospective randomized trial of arginine vasopressin in the treatment of vasodilatory shock after left ventricular assist device placement. Circulation 1997; 96:286-90
7. Argenziano M, Chen JM, Choudri AF, Cullinane S, Garfein E, Weinberg AD, Smith CR Jr, Rose EA, Landry DW, Oz MC: Management of vasodilatory shock after cardiac surgery: Identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg 1998; 116:973-80
8. Rosenzweig EB, Stare TJ, Chen JM, Cullinane S, Timchak DM, Gersony WM, Landry DW, Galantowicz ME: Intravenous arginine-vasopressin in children with vasodilatory shock after cardiac surgery. Circulation 1999; 100:182-6
9. Chen JM, Cullinane S, Spanier TB, Artrip JH, John R, Edwards NM, Oz MC, Landry DW: Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 1999; 100:244-6
10. Holmes CL, Patel BM, Russell JA, Walley KR: Physiology of vasopressin relevant to the management of septic shock. Chest 2001; 120:989-1002
11. Reid IA: Role of vasopressin deficiency in the vasodilation of septic shock. Circulation 1997; 95:1108-10
12. Day TA, Randle JC, Renaud LP: Opposing alpha and beta-adrenergic mechanisms mediate dose-dependent actions of norepinephrine on supraoptic vasopressin neurons in vivo. Brain Res 1985; 358:171-9
13. Prys-Roberts C, Farndon JR: Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World J Surg 2002; 26:1037-42
14. Pacak K, Linehan WM, Eisenhofer G, Walther MM, Goldstein DS: Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001; 134:315-29
15. Steinsapir J, Carr AA, Prisant LM, Bransome ED Jr: Metyrosine and pheochromocytoma. Arch Intern Med 1997; 157:901-6